Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells

Endocrine-Related Cancer

Volumn 15, Issue 2, 2008, Pages 521-534

  Balthasar, Sonja ^a   Bergelin, Nina ^a,b   Löf, Christoffer ^a   Vainio, Minna ^b   Andersson, Sture ^c   Törnquist, Kid ^a,d  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; THYROTROPIN; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FOLLICULAR CARCINOMA; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; THYROID CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOPHOSPHOLIPIDS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHINGOSINE; THYROID NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 45849126915     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0253     Document Type: Article

References (49)

1. Anliker B & Chun J 2004 Cell surface receptors in lysophospholipid signalling. Seminars in Cell and Developmental Biology 15 457-465.
2. Balthasar S, Samulin J, Ahlgren H, Bergelin N, Lundqvist M, Toescu EC, Eggo MC & Törnquist K 2006 Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Biochemical Journal 398 547-556.
3. Baudhuin LM, Jiang Y, Zaslavsky A, Ishii I, Chun J & Xu Y 2004 S1P3-mediated Akt activation and crosstalk with platelet-derived growth factor receptor (PDGFR). FASEB Journal 18 341-343.
4. Belletti B, Ferraro P, Arra C, Baldessarre G, Bruni P, Staibano S, De Rosa G, Salvatore G, Fusco A, Persico MG et al. 1999 Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene. Oncogene 18 4860-4869.
5. Carmeliet P 2005 VEGF as a key mediator of angiogenesis in cancer. Oncology 69 4-10.
6. Chalfant CE & Spiegel S 2005 Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signalling. Journal of Cell Science 118 4605-4612.
7. Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W, Pyne S & Tigyi G 2002 International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacological Reviews 54 265-269.
8. Edsall LC, Cuvillier O, Twitty S, Spiegel S & Milstien S 2001 Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. Journal of Neurochemistry 76 1573-1584.
9. Endo A, Nagashima K-I, Kurose H, Mochizuki S, Matsuda M & Mochizuki N 2002 Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII. Journal of Biological Chemistry 277 23747-23754.
10. Fieber CB, Eldridge J, Taha TA, Obeid LM & Muise-Helmericks RC 2006 Modulation of total Akt kinase by increased expression of a single isoform: requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells. Experimental Cell Research 312 1164-1173.
11. Hughes SK, Wacker BK, Kaneda MM & Elbert DL 2005 Fluid shear stress modulates cell migration induced by sphingosine 1-phosphate and vascular endothelial growth factor. Annals of Biomedical Engineering 33 1003-1014.
12. Igarashi J, Erwin PA, Dantas AP, Chen H & Michel T 2003 VEGF induces S1P1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors. PNAS 100 10664-10669.
13. Ishii I, Fukushima N, Ye X & Chun J 2004 Lysophospholipid receptors: signalling and biology. Annual Review of Biochemistry 73 321-354.
14. Kim DS, Franklyn JA, Boelaert K, Eggo MC, Watkinson JC & McCabe CJ 2007 Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a VEGF/KDR/ID# autocrine pathway. Journal of Clinical Endocrinology and Metabolism 91 4603-4611.
15. Liu F, Verin AD, Wang P, Day R, Wersto RP, Chrest FJ, English DK & Garcia JGN 2001 Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of Giα2-linked Rho kinase activity. American Journal of Respiratory Cell and Molecular Biology 24 711-719.
16. Morales-Ruiz M, Lee M-J, Zöllner S, Gratton J-P, Scotland R, Shiojima I, Walsh K, Hla T & Sessa WC 2001 Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/ phosphoinositide 3-kinase pathway in endothelial cells. Journal of Biological Chemistry 276 19672-19677.
17. Moretti F, Nannai S, Farsetti A, Narducci M, Crescenzi M, Giuliacci S, Sacchi A & Pontecorvi A 2000 Effects of exogenous p53 transduction in thyroid tumor cells with different p53 status. Journal of Clinical Endocrinology and Metabolism 85 302-308.
18. Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, Ui M & Okajima F 2000 Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochemical Journal 352 809-815.
19. Nordstedt C & Fredholm BB 1990 A modification of a protein binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Analytical Biochemistry 189 231-234.
20. Ogretmen B & Hannun YA 2004 Biologically active sphingolipids in cancer pathogenesis and treatment. Nature Reviews. Cancer 4 604-616.
21. Oh SH, Woo JK, Yazici YD, Myers JN, Kim W-Y, Jin Q, Hong SS, Park H-J, Suh Y-G, Kim K-W et al. 2007 Structural basis for depletion of heat shock protein 90 client protein by deguelin. Journal of the National Cancer Institute 99 949-961.
22. Olsson A-K, Dimberg A, Kreuger J & Claesson-Welsh L 2006 VEGF receptor signalling - in control of vascular function. Nature Reviews. Molecular Cell Biology 7 359-371.
23. Pacifico F, Mauro C, Barone C, Crescenzi E, Mellone S, Monaco M, Chiapetta G, Terrazzano G, Liguoro D, Vito P et al. 2004 Oncogenic and anti-apoptotic activity of NFκB in human thyroid carcinomas. Journal of Biological Chemistry 279 54610-54619.
24. Poulaki V, Mitsiades CS, McMullan C, Sykoutri D, Fanourakis G, Kotoula V, Tseleni-Balafouta S, Koutras DA & Mitsiades N 2003 Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism 88 5392-5398.
25. Radeff-Huang J, Seasholtz TM, Matteo RG & Brown JH 2004 G protein mediated signalling pathways in lysophospholipid induced cell proliferation and survival. Journal of Cellular Biochemistry 92 949-966.
26. Rey JM, Pujol PM, Callier P, Cavailles V, Freis G, Maudelonde T & Brouillet JP 2000 Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway. Journal of Molecular Endocrinology 24 433-440.
27. Rice P, Longden I & Bleasby A 2000 EMBOSS: The European molecular biology open software suite. Trends in Genetics 16 276-277.
28. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S & Shibuya M 1995 Stimulation by thyroid-stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and fit mRNA expression in the rat thyroid in vivo. Journal of Clinical Investigation 96 1295-1302.
29. Schönberger J, Bauer J, Spruß T, Weber G, Chahoud I, Eilles C & Grimm D 2000 Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. Journal of Molecular Medicine 78 102-110.
30. Shah BH & Catt KJ 2004 GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences. Trends in Neurosciences 27 48-53.
31. Shida D, Kitayama J, Yamaguchi H, Yamashita H, Mori K, Watanabe T, Yatomi Y & Nagawa H 2004 Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells. FEBS Letters 577 333-338.
32. Shu X, Wu W, Mosteller RD & Broek D 2002 Sphingosine kinase mediates vascular endothelial growth factor-induced activation of Ras and mitogen-activated protein kinases. Molecular and Cellular Biology 22 7758-7768.
33. Soh Y, Sobhi SA, Wong MG, Meng YG, Siperstein AE, Clark OH & Duh Q-Y 1996 Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. Surgery 120 944-946.
34. Spiegel S & Milstien S 2003 Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways. Biochemical Society Transactions 31 1216-1219.
35. Spiegel S, English D & Milstien S 2002 Sphingosine 1-phosphate signalling: providing cells with a sense of direction. Trends in Cell Biology 12 236-242.
36. Susarla R, Watkinson J & Eggo M 2005a Functional significance of expression of the receptors for vascular endothelial growth factors on thyroid follicular cells. Thyroid 15 S-21.
37. Susarla R, Watkinson J & Eggo M 2005b Regulation of human thyroid endothelial cells. Thyroid 15 S-91.
38. Taha TA, Argraves KM & Obeid LM 2004 Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochimica et Biophysica Acta 1682 48-55.
39. Takuwa Y 2002 Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. Biochimica et Biophysica Acta 1582 112-120.
40. Tammela T, Enholm B, Alitalo K & Paavonen K 2005 The biology of vascular endothelial growth factors. Cardiovascular Research 65 550-563.
41. Tanimoto T, Jin Z-G & Berk BC 2002 Transactivation of VEGF receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and eNOS. Journal of Biological Chemistry 277 42997-43001.
42. Turner HE, Harris A, Melmed S & Wass JAH 2003 Angiogenesis in endocrine tumors. Endocrine Reviews 24 600-632.
43. Vieira JM, Santos SCR, Espadinha C, Correia I, Vag T, Casalou C, Cavaco BM, Catarino AS, Dias S & Leite V 2005 Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop. European Journal of Endocrinology 153 701-709.
44. Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT et al. 1997 Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene 15 2687-2698.
45. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS et al. 2006 Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9 225-238.
46. Waters C, Pyne S & Pyne NJ 2004 The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Seminars in Cell and Developmental Biology 15 309-323.
47. Yamamura S, Yatomi Y, Ruan F, Sweeney A, Hakomori S-I & Igarashi Y 1997 Sphingosine 1-phosphate regulates melanoma cell motility through a receptor-coupled extracellular action and in a pertussis toxin-insensitive manner. Biochemistry 36 10751-10759.
48. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y & Kume S 1997 Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. Journal of Biochemistry 121 969-973.
49. Yatomi Y, Ozaki Y, Ohmori T & Igarashi Y 2001 Sphingosine 1-phosphate: synthesis and release. Prostaglandins and Other Lipid Mediators 64 107-122.